Szisztémás szklerózis (szkleroderma): vizsgálatok itt: Franciaország
57 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 13.. Ask the study team whether a trial fits you.
- 2. fázisNot yet taking people in FranciaországOBINUSS - A trial to evaluate a new drug in systemic sclerosis: obinutuzumab.
- Where
- Amiens Cedex 1, Angers, Angouleme Cedex 9, Avignon, Bobigny Cedex, Bordeaux, Caen, Clermont-Ferrand, Contamine-sur-Arve, Creteil Cedex, Dax, Dijon, Le Kremlin-Bicetre, Le Mans Cedex 9, Lille, Limoges, Lomme Cedex, Marseille, Montivilliers, Nantes, Nice, Niort, Orleans Cedex 2, Paris, Paris Cedex 10, Perpignan Cedex, Reims Cedex, Rennes, Rouen, Saint-Priest-en-Jarez, Strasbourg Cedex, Strasbourg Cedex 2, Toulon Cedex 9, Toulouse, Tours, Valenciennes, Vandoeuvre Les Nancy, Vantoux
- Életkor
- 18 év and over
- People
- 74
- Run by
- Assistance Publique Hopitaux De Paris
See details and how to join2025-524003-68-00 - 3. fázisTaking peopleRollover Study for Participants Who Have Completed a Previous Clinical Study With Anifrolumab (Saphnelo) and Clinically Benefited From Continued Treatment
- Where
- Bordeaux, Nantes, Paris, Poitiers, Rennes, Strasbourg, Toulouse
- Életkor
- 5 év to 80 év
- People
- 1072 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07691970 - No phaseNot yet taking people in FranciaországSmall Airway Dysfunction in Rheumatoid Arthritis and Systemic Sclerosis
- Where
- Paris
- Életkor
- 18 év and over
- People
- 184
- Run by
- Assistance Publique - Hôpitaux de Paris
See details and how to joinNCT07924124 - No phaseTaking peopleTissue Modeling in Systemic Sclerosis Using Induced Pluripotent Stem Cells (iPSCs)
- Where
- Montpellier
- Életkor
- 18 év to 85 év
- People
- 16
- Run by
- University Hospital, Montpellier
See details and how to joinNCT07650565 - 3. fázisNot yet taking people in FranciaországRollover Study for Participants Who Have Completed a Previous Clinical Study with Anifrolumab (Saphnelo) and Clinically Benefited from Continued Treatment.
- Where
- Bordeaux Cedex, Paris, Strasbourg Cedex 2, Toulouse Cedex 9
- People
- 340 worldwide
- Run by
- AstraZeneca AB
See details and how to join2026-526419-13-00 - No phaseNot yet taking people in FranciaországA Clinical Study on Systemic Sclerosis and the Validation of French-language Questionnaires Assessing Disability, Quality of Life, and Disease Status.
- Where
- Paris
- Életkor
- 18 év and over
- People
- 200
- Run by
- Assistance Publique - Hôpitaux de Paris
See details and how to joinNCT07888842 - 2. fázisTaking peopleSUBCUTANEOUS INJECTIONS OF AUTOLOGOUS CULTURED ADIPOSE-DERIVED STROMA/ STEM CELLS TO HEAL REFRACTORY ISCHEMIC DIGITAL ULCERS IN PATIENTS WITH SCLERODERMA
- Where
- Caen Cedex 9, Dijon, Grenoble Cedex 9, Lille, Montpellier Cedex 5, Nantes, Toulouse Cedex 9
- Életkor
- 18 év to 64 év
- People
- 32
- Run by
- Centre Hospitalier Universitaire De Toulouse
See details and how to join2023-508432-53-00 - 2. fázisTaking peopleEvaluation of MTX-474 in Participants with Diffuse Cutaneous Systemic Sclerosis (dcSSc)
- Where
- Grenoble, Montpellier Cedex 5, Paris, Strasbourg, Toulouse Cedex 9, Vandoeuvre-lès-Nancy
- Életkor
- 18 év and over
- People
- 36 worldwide
- Run by
- Mediar Therapeutics Inc.
See details and how to join2025-523288-39-00 - 2. fázisTaking peoplePhase IIa Trial of Anti-CD19 CAR T-Cells in Systemic Sclerosis Resistant to Immunosuppressive Therapy
- Where
- Lille, Montpellier, Paris, Rouen
- Életkor
- 18 év to 64 év
- People
- 6
- Run by
- University Hospital, Montpellier
See details and how to joinNCT07493395 - 3. fázisTaking peopleA Study to Test Whether Nerandomilast Helps People With Systemic Sclerosis
- Where
- Bordeaux, Brest, Caen, Epagny Metz-tessy, Marseille, Nancy Cedex, Nantes, Paris, Rennes, Strasbourg Cedex, Toulouse Cedex 9, Tours Cedex 9
- Életkor
- 18 év and over
- People
- 448 worldwide
- Run by
- Boehringer Ingelheim
See details and how to joinNCT07497087 · EU 2025-523884-39-00 - 1. fázisNot yet taking people in FranciaországA Study of BMS-986553 in Participants With Refractory Autoimmune Diseases
- Where
- Montpellier, Paris
- Életkor
- 18 év and over
- People
- 60 worldwide
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT07873931 - 2. fázisTaking peopleA Phase IIa Trial Evaluating the Efficacy of anti-CD19 Chimeric Antigen Receptor Engineered T-Cells in Patients With Systemic Sclerosis (SSc) Resistant to Immunosuppressive Drugs. SCLEROCAR
- Where
- Lille, Montpellier Cedex 5, Paris
- Életkor
- 18 év to 64 év
- People
- 6
- Run by
- Centre Hospitalier Universitaire De Montpellier
See details and how to join2024-519511-33-00 - 2. fázisTaking peopleEncompaSSc: Evaluation of MTX-474 in Participants With Diffuse Cutaneous Systemic Sclerosis (dcSSc)
- Where
- La Tronche, Montpellier, Paris, Strasbourg, Toulouse, Vandœuvre-lès-Nancy
- Életkor
- 18 év and over
- People
- 85 worldwide
- Run by
- Mediar Therapeutics
See details and how to joinNCT07287670 - 2. fázisTaking peopleSafety and Tolerability of TOP-N53 Applied on Digital Ulcers in Patients With Systemic Sclerosis
- Where
- Bordeaux, Grenoble Cedex 9, Lille, Paris
- Életkor
- 18 év and over
- People
- 15 worldwide
- Run by
- Topadur Pharma AG
See details and how to joinNCT06954597 · EU 2024-511861-12-00 - 2. fázisNot yet taking people in FranciaországObinutuzumab in Systemic Sclerosis
- Where
- Paris
- Életkor
- 18 év and over
- People
- 120
- Run by
- Assistance Publique - Hôpitaux de Paris
See details and how to joinNCT07842523 - No phaseNot yet taking people in FranciaországInvestigation of Type I Interferon Excess in Patients With Systemic Autoimmune Diseases and Genetic Type I Interferonopathies
- Where
- Bron, Lyon, Oullins
- Életkor
- 6 év to 60 év
- People
- 120
- Run by
- Hospices Civils de Lyon
See details and how to joinNCT07837986 - 3. fázisNot yet taking people in FranciaországA Study to Compare the Efficacy and Safety of BMS-986353 (Zolacabtagene- Autoleucel / Zola-cel), CD19-CAR T Cells, Versus Standard of Care in Participants With Active Systemic Sclerosis
- Where
- Bordeaux, Bron, Paris, Rennes, Strasbourg Cedex 2, Toulouse Cedex 9
- Életkor
- 16 év and over
- People
- 92 worldwide
- Run by
- Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
See details and how to joinNCT07335562 · EU 2025-524337-11-00 - 2. fázisNot yet taking people in FranciaországRituximab vs Placebo for Maintenance in Systemic Sclerosis - Interstitial Lung Disease
- Where
- Paris
- Életkor
- 18 év and over
- People
- 120
- Run by
- Assistance Publique - Hôpitaux de Paris
See details and how to joinNCT07827742 · EU 2025-521331-36-00 - 2. fázisTaking peopleSubcutaneous Injection of Sodium Thiosulfate for Ectopic Calcifications or Ossifications. A Pilot Study
- Where
- Bordeaux, Bron, Le Kremlin-Bicetre, Limoges, Paris, Paris Cedex 10, Paris Cedex 13, Rennes, Rouen Cedex, Toulouse, Toulouse Cedex 9
- Életkor
- 6 hónap to 64 év
- People
- 40
- Run by
- University Hospital, Limoges
See details and how to joinNCT03582800 · EU 2024-511620-13-00 - 3. fázisTaking peopleA Study to Investigate the Long-term Safety and Efficacy of Belimumab in Adults With Interstitial Lung Disease (ILD) Associated With Systemic Sclerosis (SSc) and Other Connective Tissue Diseases (CTD) (BLISSconneCTD-OLE)
- Where
- Toulouse
- Életkor
- 18 év and over
- People
- 514 worldwide
- Run by
- GlaxoSmithKline
See details and how to joinNCT06716606 - 2/3. fázisTaking peopleA Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease
- Where
- Bobigny, Brest, Paris, Paris Cedex 13, Toulouse Cedex 9
- Életkor
- 18 év and over
- People
- 300 worldwide
- Run by
- GlaxoSmithKline
See details and how to joinNCT05878717 · EU 2023-503219-14-01 - 1. fázisNot yet taking people in FranciaországStudy Investigating the Safety of Anti-CD19 CAR-T Cells Therapy Produced at Gustave Roussy for Adults With Severe and Refractory Systemic Autoimmune Rheumatic Diseases
- Where
- Villejuif
- Életkor
- 18 év to 75 év
- People
- 6
- Run by
- Gustave Roussy, Cancer Campus, Grand Paris
See details and how to joinNCT07544225 - No phaseTaking peopleCharacterization of Autoreactive b Lymphocytes in Autoimmune Diseases and Immune Deficiencies
- Where
- Strasbourg
- Életkor
- 18 év to 70 év
- People
- 200
- Run by
- University Hospital, Strasbourg, France
See details and how to joinNCT07251179 - No phaseTaking peoplePeriodontal Microbiota in Systemic Sclerosis
- Where
- Strasbourg
- Életkor
- 18 év and over
- People
- 30
- Run by
- University Hospital, Strasbourg, France
See details and how to joinNCT06182293 - 2. fázisTaking peoplePlatform Clinical Study for Conquering Scleroderma
- Where
- Bobigny, Bron, Grenoble Cedex 9, Lille Cedex, Pessac Cedex, Rennes, Strasbourg Cedex, Toulouse
- Életkor
- 18 év and over
- People
- 400 worldwide
- Run by
- Scleroderma Research Foundation, Inc.
See details and how to joinNCT06195072 · EU 2023-507129-40-00